10-Cent Pill Could Transform Heart Failure Treatment Worldwide
SciTechDaily • • health
Key Points:
- New research led by UMCG cardiologists suggests that low-dose digoxin can significantly reduce hospital admissions and mortality risk in heart failure patients, potentially influencing future treatment guidelines.
- A meta-analysis combining new and previous studies showed a roughly 25% reduction in heart failure-related hospitalizations when low-dose digoxin was added to standard therapy, confirming its safety and efficacy.
- Discontinuation of digoxin in patients previously treated with the drug was linked to increased complications, highlighting its ongoing benefit in managing heart failure.
- Digoxin, an inexpensive and long-used medication, works at low doses by reducing harmful stress hormone levels rather than increasing heart contraction strength, contrasting with past higher-dose practices.
- Despite declining use due to newer treatments, this research, supported by a €3 million investment from Hartstichting and ZonMw, underscores the value of revisiting low-cost drugs for improving heart failure care.